183 related articles for article (PubMed ID: 27474203)
1. JAK-mediated autophagy regulates stemness and cell survival in cisplatin resistant bladder cancer cells.
Ojha R; Singh SK; Bhattacharyya S
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2484-2497. PubMed ID: 27474203
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine and mitomycin induced autophagy regulates cancer stem cell pool in urothelial carcinoma cells.
Ojha R; Jha V; Singh SK
Biochim Biophys Acta; 2016 Feb; 1863(2):347-59. PubMed ID: 26658162
[TBL] [Abstract][Full Text] [Related]
3. miR34a/GOLPH3 Axis abrogates Urothelial Bladder Cancer Chemoresistance via Reduced Cancer Stemness.
Zhang Q; Zhuang J; Deng Y; Yang L; Cao W; Chen W; Lin T; Lv X; Yu H; Xue Y; Guo H
Theranostics; 2017; 7(19):4777-4790. PubMed ID: 29187903
[No Abstract] [Full Text] [Related]
4. Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer.
Liu C; Pan Z; Chen Q; Chen Z; Liu W; Wu L; Jiang M; Lin W; Zhang Y; Lin W; Zhou R; Zhao L
J Exp Clin Cancer Res; 2021 Sep; 40(1):297. PubMed ID: 34551797
[TBL] [Abstract][Full Text] [Related]
5. Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin.
Yang Y; Fan Y; Qi Y; Liu D; Wu K; Wen F; Zhao S
Oncol Rep; 2015 Aug; 34(2):929-35. PubMed ID: 26081992
[TBL] [Abstract][Full Text] [Related]
6. Autophagy regulates cisplatin-induced stemness and chemoresistance via the upregulation of CD44, ABCB1 and ADAM17 in oral squamous cell carcinoma.
Naik PP; Mukhopadhyay S; Panda PK; Sinha N; Das CK; Mishra R; Patil S; Bhutia SK
Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29171106
[TBL] [Abstract][Full Text] [Related]
7. Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells.
Kang M; Lee KH; Lee HS; Jeong CW; Kwak C; Kim HH; Ku JH
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28165387
[TBL] [Abstract][Full Text] [Related]
8. Targeting cancer initiating cells by promoting cell differentiation and restoring chemosensitivity via dual inactivation of STAT3 and src activity using an active component of antrodia cinnamomea mycelia.
Chang CW; Chen YS; Chen CC; Chan IO; Chen CC; Sheu SJ; Lin TW; Chou SH; Liu CJ; Lee TC; Lo JF
Oncotarget; 2016 Nov; 7(45):73016-73031. PubMed ID: 27682875
[TBL] [Abstract][Full Text] [Related]
9. The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
Hayden A; Douglas J; Sommerlad M; Andrews L; Gould K; Hussain S; Thomas GJ; Packham G; Crabb SJ
Urol Oncol; 2014 Aug; 32(6):806-14. PubMed ID: 24837013
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer.
Zhang Y; Wang Z; Yu J; Shi Jz; Wang C; Fu Wh; Chen Zw; Yang J
Cancer Lett; 2012 Sep; 322(1):70-7. PubMed ID: 22343321
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.
Zhang T; Jiang B; Zou ST; Liu F; Hua D
World J Gastroenterol; 2015 Feb; 21(6):1804-13. PubMed ID: 25684945
[TBL] [Abstract][Full Text] [Related]
12. STAT3 signaling pathway in drug-resistant bladder cancer cell line.
Lei T; Zhou S; Meng Q; Zhang M
J Biol Regul Homeost Agents; 2019; 33(5):1347-1357. PubMed ID: 31912690
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
14. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
[TBL] [Abstract][Full Text] [Related]
16. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
[TBL] [Abstract][Full Text] [Related]
17. Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway.
Li H; Lu Y; Pang Y; Li M; Cheng X; Chen J
Biomed Pharmacother; 2017 Feb; 86():324-333. PubMed ID: 28011380
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin.
Yan Z; Jiang J; Li F; Yang W; Xie G; Zhou C; Xia S; Cheng Y
Oncol Rep; 2015 Apr; 33(4):1791-8. PubMed ID: 25695283
[TBL] [Abstract][Full Text] [Related]
19. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
[TBL] [Abstract][Full Text] [Related]
20. Autophagy inhibition suppresses the tumorigenic potential of cancer stem cell enriched side population in bladder cancer.
Ojha R; Jha V; Singh SK; Bhattacharyya S
Biochim Biophys Acta; 2014 Nov; 1842(11):2073-86. PubMed ID: 25020236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
